Adcock Ingram Holdings reported ZAR1.05B in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Adcock Ingram Holdings ZAR 1.05B 50.17M Dec/2024
Alaunos Therapeutics USD 845K 162K Dec/2024
Aspen Pharmacare ZAR 5.37B 230M Dec/2024
Avita Medical AUD 21.23M 2.57M Dec/2024
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
IQVIA Holdings USD 509M 1000K Jun/2025
Life Healthcare 197M 76M Sep/2024
Moderna USD 230M 18M Jun/2025
Netcare ZAR 5.01B 380M Sep/2024
Organon & Co USD 453M 33M Jun/2025
Revvity USD 248.53M 1.19M Jun/2025
Tectonic Therapeutic USD 5.15M 315K Jun/2025
Viatris USD 928.7M 111.2M Jun/2025
Xeris Pharmaceuticals USD 44.39M 35.89M Jun/2025